You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 214965


✉ Email this page to a colleague

« Back to Dashboard


NDA 214965 describes VERKAZIA, which is a drug marketed by Harrow Eye and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the VERKAZIA profile page.

The generic ingredient in VERKAZIA is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 214965
Tradename:VERKAZIA
Applicant:Harrow Eye
Ingredient:cyclosporine
Patents:7
Suppliers and Packaging for NDA: 214965
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965 NDA Santen Incorporated 65086-001 65086-001-05 1 POUCH in 1 CARTON (65086-001-05) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSE
VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965 NDA Santen Incorporated 65086-001 65086-001-12 24 POUCH in 1 CARTON (65086-001-12) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:EMULSION;OPHTHALMICStrength0.1%
Approval Date:Jun 23, 2021TE:RLD:Yes
Regulatory Exclusivity Expiration:Jun 23, 2028
Regulatory Exclusivity Use:FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS (VKC) IN CHILDREN AND ADULTS
Regulatory Exclusivity Expiration:Jun 23, 2024
Regulatory Exclusivity Use:NEW PRODUCT
Patent:⤷  Sign UpPatent Expiration:Jan 27, 2026Product Flag?Substance Flag?Delist Request?
Patented Use:FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.